1,030
Participants
Start Date
May 2, 2019
Primary Completion Date
June 20, 2022
Study Completion Date
July 18, 2023
Pembrolizumab
IV infusion
Docetaxel
IV infusion
Prednisone
Oral tablets
Placebo
IV infusion
Dexamethasone
Oral tablets
National Cheng Kung University Hospital ( Site 0134), Tainen
Medizinische Universitaet Wien ( Site 0375), Vienna
Saitama Medical University International Medical Center ( Site 0708), Hidaka
Macquarie University ( Site 0151), Macquarie University
St George Hospital ( Site 0157), Kogarah
Calvary Mater Newcastle ( Site 0148), Waratah
Port Macquarie Base Hospital ( Site 0153), Port Macquarie
Redcliffe Hospital ( Site 0161), Redcliffe
Ordensklinikum Linz GmbH Elisabethinen ( Site 0373), Linz
John Flynn Hospital & Medical Centre ( Site 0164), Tugun
SCRI-CCCIT GesmbH ( Site 0371), Salzburg
Hollywood Private Hospital ( Site 0163), Nedlands
Medizinische Universitat Graz ( Site 0374), Graz
National Taiwan University Hospital ( Site 0131), Taipei
Charite Universitaetsmedizin Berlin ( Site 0301), Berlin
National Cancer Center ( Site 0174), Goyang-si
Taipei Veterans General Hospital ( Site 0135), Taipei
Institut Paoli Calmettes. ( Site 0419), Marseille
Associated Medical Professionals of NY ( Site 0060), Syracuse
Seoul National University Bundang Hospital ( Site 0175), Seongnam-si
Hospital Josep Trueta ( Site 0321), Girona
Istituto Clinico Humanitas Research Hospital ( Site 0452), Rozzano
Virginia Cancer Institute ( Site 0052), Richmond
Blue Ridge Cancer Care ( Site 0086), Roanoke
CHU Jean Minjoz ( Site 0423), Besançon
Duke Cancer Center ( Site 0010), Durham
Hospital Universitario Ramon y Cajal ( Site 0328), Madrid
Hospital Clinico San Carlos ( Site 0324), Madrid
Hospital Universitario HM Sanchinarro ( Site 0322), Madrid
W. G. Bill Hefner VA Medical Center ( Site 0029), Salisbury
Hospital Universitario Virgen de la Victoria ( Site 0337), Málaga
CHU de Brest -Site Hopital Morvan ( Site 0441), Brest
Carolina Urologic Research Center ( Site 0070), Myrtle Beach
Georgia Cancer Center at Augusta University ( Site 0026), Augusta
Institut Claudius Regaud IUCT Oncopole ( Site 0418), Toulouse
Institut Bergonie ( Site 0421), Bordeaux
Moffitt Cancer Center ( Site 0080), Tampa
University of South Alabama, Mitchell Cancer Institute ( Site 0065), Mobile
Universitaetsklinikum Goettingen ( Site 0345), Göttingen
Presidio Ospedaliero Santa Chiara ( Site 0451), Trento
Hospital Universitario Marques de Valdecilla ( Site 0336), Santander
China Medical University Hospital ( Site 0132), Taichung
Taichung Veterans General Hospital ( Site 0133), Taichung
Hospital Virgen del Rocio ( Site 0329), Seville
A.O. Universitaria di Modena ( Site 0454), Modena
University Hospitals Cleveland Medical Center ( Site 0036), Cleveland
Institut De Cancerologie De L Ouest ( Site 0448), Saint-Herblain
Centre Hospitalier Regional du Orleans ( Site 0430), Orléans
Methodist Hospital- Merriillville ( Site 0008), Merrillville
Karmanos Cancer Institute ( Site 0077), Detroit
Cancer & Hematology Centers of Western Michigan ( Site 0013), Grand Rapids
Uniklinik RWTH Aachen ( Site 0308), Aachen
Centre D Oncologie de Gentilly ( Site 0432), Nancy
St. Vincent Frontier Cancer Center ( Site 0016), Billings
Mount Sinai Hospital Medical Center ( Site 0042), Chicago
Centre Jean Perrin ( Site 0434), Clermont-Ferrand
Washington University School of Medicine ( Site 0057), St Louis
Universitaetsklinikum des Saarlandes ( Site 0348), Homburg
Clinique Sainte Anne ( Site 0431), Strasbourg
Nebraska Cancer Specialists ( Site 0034), Omaha
Universitaetsklinikum in Mannheim ( Site 0314), Mannheim
C.H.U. Lyon Sud ( Site 0436), Pierre-Bénite
Centre Leon Berard ( Site 0422), Lyon
Universitaetsklinik fuer Urologie ( Site 0307), Tübingen
Studienpraxis Urologie ( Site 0309), Nürtingen
Institut Mutualiste Montsouris ( Site 0446), Paris
Universitaetsklinikum Freiburg - Medizinische Klinik ( Site 0304), Freiburg im Breisgau
CHU Amiens Picardie Site Sud Amiens ( Site 0438), Amiens
University of Colorado Cancer Center ( Site 0022), Aurora
Istituto Nazionale Tumori IRCCS Fondazione Pascale ( Site 0457), Napoli
Klinikum Rechts der Isar ( Site 0300), Munich
Institut Sainte Catherine ( Site 0447), Avignon
Comprehensive Cancer Centers of Nevada ( Site 0092), Las Vegas
University of Southern California Norris Comprehensive Cancer Center ( Site 0061), Los Angeles
Universitaetsklinik der Paracelsus Medizinischen Privatuniversitaet ( Site 0318), Nuremberg
Hopital Foch ( Site 0428), Suresnes
USC Norris Oncology Hematology Newport Beach ( Site 0093), Newport Beach
St. Joseph Heritage Healthcare ( Site 0069), Fullerton
University of California San Francisco ( Site 0023), San Francisco
Institut Gustave Roussy ( Site 0416), Villejuif
Azienda Ospedaliera Cannizzaro ( Site 0458), Catania
Universitaetsklinikum Wuerzburg ( Site 0302), Würzburg
Oregon Health Sciences University ( Site 0031), Portland
Peking University First Hospital ( Site 1303), Beijing
The Fifth Medical Center of PLA General Hospital ( Site 1307), Beijing
Beijing Cancer Hospital ( Site 1305), Beijing
SBIH City clinical hospital named after D.D. Pletniov ( Site 0575), Moscow
Instituto Nacional de Cancerologia E.S.E ( Site 1061), Bogotá
Clinica Colsanitas S.A. Sede Clinica Universitaria Colombia ( Site 1062), Bogotá
Russian Scientific Center of Radiology ( Site 0559), Moscow
Central Clinical Hospital with Polyclinic ( Site 0562), Moscow
National Medical Research Radiological Center ( Site 0556), Moscow
Harbin Medical University Cancer Hospital ( Site 1326), Harbin
Leningrad Regional Oncology Center ( Site 0588), Saint Petersburg
Clinical Research Center of specialized types medical care-Oncology ( Site 0570), Saint Petersburg
Russian Scientific Center of Radiology and Surgical Technologies ( Site 0567), Saint Petersburg
SPb SBHI City Clinical Oncological Dispensary ( Site 0571), Saint Petersburg
Sociedad de Oncología Y Hematología del Cesar S.A.S. ( Site 1068), Valledupar
Fudan University Shanghai Cancer Center ( Site 1300), Shanghai
Zhongshan Hospital Fudan University ( Site 1301), Shanghai
Nanjing Drum Tower Hospital ( Site 1312), Nanjing
Oncomedica S.A. ( Site 1057), Montería
The Second Affiliated Hospital of Zhejiang University School of Medicine ( Site 1309), Hangzhou
Zhejiang Provincial People's Hospital ( Site 1310), Hangzhou
The First Affiliated Hospital of Xiamen University ( Site 1319), Xiamen
Hunan Cancer Hospital ( Site 1320), Changsha
Hubei Cancer Hospital ( Site 1329), Wuhan
SBHI Samara Regional Clinical Oncology Dispensary ( Site 0576), Samara
Henan Cancer Hospital ( Site 1321), Zhengzhou
Chelyabinsk Regional Clinical Oncological Dispensary ( Site 0565), Chelyabinsk
Sun Yat Sen Memorial Hospital ( Site 1323), Guangzhou
The First Affiliated Hospital of Guangzhou Medical University ( Site 1330), Guangzhou
Volga District Medical Center Federal Medical and Biological Agency ( Site 0572), Nizhny Novgorod
Tomsk National Research Medical Center of Russian Academy of Sciences ( Site 0579), Tomsk
Omsk Clinical Oncology Dispensary ( Site 0568), Omsk
Oncologos del Occidente S.A. ( Site 1072), Pereira
Krasnoyarsk Regional Clinical Oncological Dispensary ( Site 0585), Krasnoyarsk
Centro Medico Imbanaco de Cali S.A ( Site 1064), Santiago de Cali
Hemato Oncologos S.A. ( Site 1065), Santiago de Cali
Centro de Investigaciones Clinicas Vina del Mar ( Site 1042), Viña del Mar
Rambam Medical Center ( Site 0543), Haifa
Meir Medical Center ( Site 0544), Kfar Saba
Centro Investigación del Cáncer James Lind ( Site 1041), Temuco
Rey y Oreilly Limitada ( Site 1048), Temuco
Rabin Medical Center ( Site 0545), Petah Tikva
Chaim Sheba Medical Center ( Site 0541), Ramat Gan
Sourasky Medical Center ( Site 0542), Tel Aviv
Assaf Harofeh MC ( Site 0547), Beer Yaakov-Zerifin
Fundacion Arturo Lopez Perez ( Site 1049), Santiago
Pontificia Universidad Catolica de Chile ( Site 1047), Santiago
Soroka Medical Center ( Site 0548), Beersheba
Bradford Hill Centro de Investigaciones Clinicas ( Site 1044), Santiago
Hadassah Ein Kerem Medical Center ( Site 0546), Jerusalem
Yale Cancer Center ( Site 0038), New Haven
Henry Ford Health System ( Site 0039), Detroit
John Theurer Cancer Center at Hackensack University Medical Center ( Site 0004), Hackensack
Inova Schar Cancer Institute ( Site 0006), Fairfax
Centro de Oncologia e Investigacion Buenos Aires COIBA ( Site 1013), Berazategui
Instituto de Investigaciones Clinicas ( Site 1000), Mar del Plata
Centro de Diagnostico Urologico ( Site 1008), Buenos Aires
Hospital Britanico de Buenos Aires ( Site 1006), Buenos Aires
Sanatorio Parque ( Site 1002), Rosario
Instituto de Investigaciones Metabolicas [Buenos Aires, Argentina] ( Site 1011), Buenos Aires
Hospital Aleman ( Site 1004), Buenos Aires
Instituto Medico Alexander Fleming ( Site 1010), Buenos Aires
CEMAIC ( Site 1014), Córdoba
Hospital de Caridade de Ijui ( Site 1038), Ijuí
Uniao Brasileira de Educacao e Assistencia Hospital Sao Lucas da Pucrs ( Site 1021), Porto Alegre
Centro de Novos Tratamentos Itajai - Clinica de Neoplasias Litoral ( Site 1035), Itajaí
Hospital de Base de Sao Jose de Rio Preto ( Site 1022), São José do Rio Preto
A.C. Camargo Cancer Center ( Site 1026), São Paulo
Nova Scotia Health Authority QEII-HSC ( Site 0114), Halifax
Hamilton Health Sciences-Juravinski Cancer Centre ( Site 0116), Hamilton
Grand River Hospital ( Site 0120), Kitchener
Lakeridge Health ( Site 0117), Oshawa
Sunnybrook Research Institute ( Site 0108), Toronto
Princess Margaret Cancer Centre ( Site 0107), Toronto
CHU de Quebec-Universite Laval-Hotel Dieu de Quebec ( Site 0103), Québec
CIUSSS du Bas Saint Laurent - Hopital Regional de Rimouski ( Site 0102), Rimouski
CIUSSS de l Estrie - CHUS - Centre Hosp. Univ. Sherbrooke ( Site 0105), Sherbrooke
Hospital Pablo Tobon Uribe ( Site 1066), Medellín
Biomelab S A S ( Site 1067), Barranquilla
Clinica de la Costa Ltda. ( Site 1073), Barranquilla
C.H. de Saint Quentin ( Site 0481), Saint-Quentin
Universitaetsklinikum Jena ( Site 0305), Jena
Cork University Hospital ( Site 0727), Cork
Tallaght University Hospital ( Site 0730), Dublin
Mid Western Cancer Centre ( Site 0728), Limerick
Azienda Ospedaliera San Camillo Forlanini ( Site 0455), Roma
Azienda Ospedaliera Santa Maria Terni ( Site 0456), Terni
National Cancer Center Hospital East ( Site 0702), Kashiwa
Toho University Sakura Medical Center ( Site 0703), Sakura
National Hospital Organization Shikoku Cancer Center ( Site 0716), Matsuyama
Kanazawa University Hospital ( Site 0701), Kanazawa
Kitasato University Hospital ( Site 0705), Sagamihara
Yokohama City University Medical Center ( Site 0706), Yokohama
Nara Medical University Hospital ( Site 0715), Kashihara
Kindai University Hospital ( Site 0714), Sayama
Osaka University Hospital ( Site 0713), Suita
Dokkyo Medical University Saitama Medical Center ( Site 0707), Koshigaya
Hamamatsu University Hospital ( Site 0720), Hamamatsu
Yamaguchi University Hospital ( Site 0717), Ube
Chiba Cancer Center ( Site 0704), Chiba
Kyushu University Hospital ( Site 0718), Fukuoka
University of Miyazaki Hospital ( Site 0721), Miyazaki
Nagasaki University Hospital ( Site 0719), Nagasaki
Toranomon Hospital ( Site 0711), Tokyo
Nippon Medical School Hospital ( Site 0709), Tokyo
Keio University Hospital ( Site 0710), Tokyo
Ziekenhuis Gelderse Vallei ( Site 0485), Ede
Radboud University Medical Center ( Site 0470), Nijmegen
VieCuri Medisch Centrum ( Site 0487), Venlo
Jeroen Bosch Ziekenhuis ( Site 1200), 's-Hertogenbosch
Catharina Ziekenhuis ( Site 0472), Eindhoven
Antoni van Leeuwenhoek Ziekenhuis ( Site 0480), Amsterdam
Ziekenhuis Hilversum ( Site 0466), Hilversum
Ziekenhuisgroep Twente ( Site 0469), Hengelo
Medisch Centrum Leeuwarden ( Site 0477), Leeuwarden
Reinier de Graaf Groep ( Site 0484), Delft
Hagaziekenhuis ( Site 1201), The Hague
Seoul National University Hospital ( Site 0171), Seoul
Asan Medical Center ( Site 0176), Seoul
Samsung Medical Center ( Site 0172), Seoul
Instituto Catalan de Oncologia - ICO ( Site 0330), L'Hospitalet de Llobregat
Hospital Consorci Sanitari Parc Tauli ( Site 0335), Sabadell
Hospital del Mar ( Site 0333), Barcelona
Hospital Clinic ( Site 0323), Barcelona
University Hospitals Bristol NHS Foundation Trust ( Site 0530), Bristol
Cambridge University Hospitals NHS Trust ( Site 0540), Cambridge
Torbay Hospital ( Site 0532), Torquay
Weston Park Hospital ( Site 0539), Sheffield
Royal Marsden Hospital ( Site 0526), Sutton
Mount Vernon Cancer Centre ( Site 0536), Northwood
Barts Cancer Institute ( Site 0483), London
University of North Midlands NHS Foundation Trust ( Site 0527), Stoke-on-Trent
Merck Sharp & Dohme LLC
INDUSTRY